Edgewise Therapeutics Inc... (EWTX)
NASDAQ: EWTX
· Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT
Edgewise Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.12M | 2.12M | 2.12M | 2.25M | 2.25M | 2.25M | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.47M | 4.44M | 4.41M | 3.88M | 2.04M | 1.94M | 1.66M | 1.22M | 935K | 652K | 538K | 524K | 423K | 320K | 272K | 194K | 130K | 79K |
Gross Profit | -2.35M | -2.32M | -2.29M | -1.63M | 212K | 309K | 593K | -1.22M | -935K | -652K | -538K | -524K | -423K | -320K | -272K | -194K | -130K | -79K |
Operating Income | -174.54M | -170.04M | -158.83M | -147.15M | -136.17M | -123.41M | -114.36M | -102.57M | -91.38M | -82.54M | -71.66M | -62.4M | -57.22M | -51.18M | -43.22M | -36.74M | -27.3M | -20.8M |
Interest Income | 23.84M | 23.95M | 25.02M | 22.86M | 20.3M | 17.56M | 14.19M | 13.14M | 10.16M | 6.72M | 4.02M | 1.48M | 843K | 526K | 402K | 278K | 152K | 48K |
Pretax Income | -150.7M | -146.09M | -133.81M | -124.29M | -115.88M | -105.85M | -100.16M | -89.44M | -81.22M | -75.82M | -67.64M | -60.92M | -56.37M | -50.66M | -42.81M | -36.46M | -27.15M | -20.75M |
Net Income | -150.7M | -146.09M | -133.81M | -124.29M | -115.88M | -105.85M | -97.06M | -83.66M | -74.69M | -68.86M | -63.62M | -59.57M | -55.78M | -50.49M | -42.81M | -36.46M | -27.15M | -20.75M |
Selling & General & Admin | 35.74M | 34.06M | 31.87M | 28.77M | 26.22M | 24.63M | 23.45M | 22.74M | 21.44M | 19.75M | 17.63M | 15.89M | 14.72M | 13.23M | 11.03M | 8.5M | 5.71M | 3.42M |
Research & Development | 139.86M | 136.5M | 126.97M | 117.33M | 108.89M | 98.25M | 90.91M | 79.83M | 69.94M | 62.78M | 54.03M | 46.51M | 42.49M | 37.95M | 32.19M | 28.24M | 21.6M | 17.38M |
Other Expenses | -1.06M | -1.06M | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 174.54M | 169.5M | 157.77M | 146.09M | 135.12M | 122.88M | 114.36M | 102.57M | 91.38M | 82.54M | 71.66M | 62.4M | 57.22M | 51.18M | 43.22M | 36.74M | 27.3M | 20.8M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 106K | 52K | n/a | -106K | -106K | -52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 174.54M | 170.04M | 158.83M | 147.15M | 136.17M | 123.41M | 114.36M | 102.57M | 91.38M | 82.54M | 71.66M | 62.4M | 57.22M | 51.18M | 43.22M | 36.74M | 27.3M | 20.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -3.11M | -5.77M | -6.54M | -6.96M | -4.02M | -1.35M | -590K | -166K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 1.56M |
Shares Outstanding (Diluted) | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 1.56M |
EPS (Basic) | -1.55 | -1.55 | -1.45 | -1.5 | -1.55 | -1.55 | -1.53 | -1.32 | -1.23 | -1.21 | -1.19 | -1.19 | -1.13 | -1.02 | -5.1 | -5.15 | -5.07 | -5.05 |
EPS (Diluted) | -1.55 | -1.55 | -1.45 | -1.5 | -1.55 | -1.55 | -1.53 | -1.32 | -1.23 | -1.21 | -1.19 | -1.19 | -1.13 | -1.02 | -5.1 | -5.15 | -5.07 | -5.05 |
EBITDA | -167.43M | -162.45M | -150.77M | -145.12M | -134.29M | -121.58M | -112.81M | -101.42M | -90.58M | -82.06M | -71.25M | -62M | -56.85M | -50.86M | -42.94M | -36.49M | -27.07M | -20.58M |
EBIT | -157.01M | -159M | -152.95M | -147.15M | -136.17M | -123.41M | -114.36M | -102.57M | -91.38M | -82.54M | -71.66M | -62.4M | -57.22M | -51.18M | -43.22M | -36.74M | -27.3M | -20.8M |
Depreciation & Amortization | 1.78M | 2.32M | 2.29M | 2.19M | 2.04M | 1.94M | 1.66M | 1.22M | 935K | 652K | 538K | 524K | 423K | 320K | 272K | 244K | 230K | 224K |